Dose dependent changes in fluorescence and forward scatter from cyanobacteria treated with H₂O₂. by Emma T. Brentjens (17295999)

Subjects:

Red and green fluorescence of <i>M</i>. <i>aeruginosa</i> cells exposed to H₂O₂ over time relative to control. by Emma T. Brentjens (17295999)

Subjects:

Average green and red fluorescence for three separate experiments at 48 and 72 hours after H₂O₂ exposure. by Emma T. Brentjens (17295999)

Subjects:

Pattern of <i>M</i>. <i>aeruginosa</i> fluorescence change with exposure to 750 μg/mL H₂O₂. by Emma T. Brentjens (17295999)

Subjects:

Dose dependent changes in fluorescence from cyanobacteria treated with H₂O₂ after normalization with forward scatter. by Emma T. Brentjens (17295999)

Subjects:

Fluorescence intensity curves of <i>M</i>. <i>aeruginosa</i> after H₂O₂ and light treatments from UV, violet, blue, yellow-green, red laser excitation. by Emma T. Brentjens (17295999)

Subjects:

Dose- and time-dependent response of <i>M</i>. <i>aeruginosa</i> fluorescence to H₂O₂ exposure. by Emma T. Brentjens (17295999)

Subjects:

Ratio of forward scatter (FSC) and side scatter (SSC) to control in <i>M</i>. <i>aeruginosa</i> exposed to H₂O₂ and UV, blue, and green light. by Emma T. Brentjens (17295999)

Subjects:

Cyanobacteria growth of treated and control cells. by Emma T. Brentjens (17295999)

Subjects:

H₂O₂-treated <i>M</i>. <i>aeruginosa</i> forward scatter (FSC) and side scatter (SSC) relative to control. by Emma T. Brentjens (17295999)

Subjects:

Fluorescence intensity curves of <i>M</i>. <i>aeruginosa</i> treated with PSII inhibitory chemicals from violet, blue, and yellow-green laser excitation. by Emma T. Brentjens (17295999)

Subjects:

<i>M</i>. <i>aeruginosa</i> treatment chemicals and doses. by Emma T. Brentjens (17295999)

Subjects:

Mean red and green fluorescence intensity data from three experiments of cyanobacteria. by Emma T. Brentjens (17295999)

Subjects:

Fluorescence intensity curves of control and 750 μg/mL H₂O₂ <i>M</i>. <i>aeruginosa</i> samples from UV, violet, blue, yellow-green, and red laser excitation.... by Emma T. Brentjens (17295999)

Subjects:

Fluorescence intensity curves of control and 750 μg/mL H₂O₂ <i>M</i>. <i>aeruginosa</i> samples from UV, violet, blue, yellow-green, and red laser excitation.... by Emma T. Brentjens (17295999)

Subjects:

Photostable Cs_0.5Rb_0.5PbBr₃ Quantum Dots for Whispering Gallery Mode Lasing by Subitan Laskar (15193108)

Subjects:

Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

“…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC₅₀ = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”

Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

“…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC₅₀ = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”

Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

Oxytocin decreases postsynaptic CeA spontaneous GABAergic transmission and blocks presynaptic alcohol effects. by Brendan J. Tunstall (6593357)

“…<p>(A, Top) Representative GABA_A-mediated sIPSCs of CeA neurons from nondependent and dependent rats prior to (baseline) and during application of oxytocin (500 nM). …”